Top-News
Biotechnologie Dänemark

Genmab A/S News

Aktie
WKN:  A1WZYB ISIN:  US3723032062 US-Symbol:  GMAB
25,80 €
+0,00 €
0,00%
31.05.24 14:26:17
Handeln Depot/Watchlist
Aktienanzahl *
653,22 Mio.
Marktkapitalisierung *
16,98 Mrd. €
Streubesitz
-
Index-Zugehörigkeit
-
IR-Website
zur Website
*Stand: 17.01.2024

Genmab A/S News

09.12.23 - PR Newswire
New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-To-Treat Relapsed/Refractory (R/R) Follicular Lymphoma (FL)
New Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Shows Strong, Durable Treatment Response for Patients with Difficult-​To-Treat Relapsed/Refractory (R/R) ...
13.11.23 - PR Newswire
Thinking about trading options or stock in Monday.Com, Boeing, Eli Lilly, Xpeng, or Genmab?
Thinking about trading options or stock in Monday.Com, Boeing, Eli Lilly, Xpeng, or Genmab? PR Newswire
13.04.22 - PR Newswire
AbbVie and Genmab Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL)
AbbVie and Genmab Announce Topline Results for Epcoritamab (DuoBody®-CD3xCD20) from Phase 1/2 Trial in Patients with Relapsed/Refractory Large B-cell Lymphoma (LBCL) ...
09.09.21 - PR Newswire
Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in The Lancet
Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-​Hodgkin's Lymphoma (B-NHL) Published in The Lancet - ...
26.03.18 - PR Newswire
Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference
Genmab A/S webcast presentation now available for on-demand viewing: dbVIC - Deutsche Bank ADR Virtual Investor Conference PR Newswire
21.03.18 - PR Newswire
International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 22, 2018
International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on March 22, 2018 PR Newswire
21.03.18 - PR Newswire
Genmab A/S to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 22, 2018
Genmab A/S to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on March 22, 2018 PR Newswire
17.04.14 - PR Newswire
GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) for whom fludarabine-based
GSK and Genmab receive FDA approval for Arzerra® (ofatumumab) as first-​line treatment in combination with chlorambucil for patients with Chronic Lymphocytic Leukaemia (CLL) ...
17.10.13 - PR Newswire
OTCM ADR Index Up 11.12% in Q3 2013, 12.75% Year-to-Date
OTCM ADR Index Up 11.12% in Q3 2013, 12.75% Year-​to-Date 67 companies joined Index in Q3, including AusTex Oil Limited, Dyesol Ltd., Invensys plc, Klabin S.A., QRxPharma ...

Newssuche

Videos

newspaper
29.05.24
Technical Trading: DAX Long Chance kurzfristig
DAX Long Typ: Turbo Open End WKN: VD5FWS Hebel: 28 Laufzeit: OpenEnd Einstieg: Market ... Mehr »